• World
  • Columnist
  • Commodities
  • WORLD BUSINESS & ECONOMY
  • Executive Knowledge Series
  • Finance
  • Manufacturing
  • Markets
  • Risk & Governance
  • Small Business
  • Technology, Media & Innovation
  • Comments
  • Business AM WebTV
  • Login

Businessamlive
  • FRONTPAGE
  • FINANCE
    • AllAsset ManagementAuditBankingBondBudgetCapital MarketsC&I LeasingCurrencyDealDebt marketForexFund RaisingFundingGovernmentHedge FundsInsuranceInvestmentInvestorInvestor ServicesMergers & AcquistionsMoney marketTreasury BillsMortgagePensionsPersonal financePonziQuantitative EasingshareTaxationTSAWealth Management
      Finance

      Amidst N32.22trn public debt, analysts say Nigeria’s external debt service manageable

      1hr

      Finance

      Stringent regulations, business environment forced Stanbic IBTC out of BDC business

      January 15, 2021

      Finance

      Cautious equities trading see gains in Flour Mills, Mobil, Wapco push market cap to ₦21.09trn

      January 15, 2021

      Finance

      CBN issues guidelines for QR codes operation in Nigeria

      January 15, 2021

  • MARKETS
  • ECONOMY
    • AllAfricaAgricAirportsAmericaAsiaAustraliaBreakthroughDealEuropeForeign InvestmentsforexGlobal marketGovernanceIMFMiddle EastNECANigeriaOutlookRich listSouth AfricaSport BusinessTradeU.KWest AfricaWorld Economic forum
      Technology

      Africa data centre market to outpace $3bn by 2025, says Turner & Townsend

      20 hrs

      Commodities

      Wheat soars as Russia considers export tax

      20 hrs

      WORLD BUSINESS & ECONOMY

      Only 20% of UK financial services professionals believe firms possess ethical commitment

      January 16, 2021

      Frontpage

      Moody’s sees negative 2021 outlook for sub-Saharan Africa, with severe economic challenges

      January 15, 2021

  • COMMODITIES
  • ENERGY
    • AllConferenceElectricityOil and GasPowerRenewable
      Frontpage

      Nigeria aims for cost efficiency, safety, value in oil sector with centre of excellence

      < 1 min

      Frontpage

      Sustainable energy: Minister estimates solution to cost Nigeria $4bn in annual spend

      1hr

      Frontpage

      NNPC receives $120.49m crude oil receipt in September  

      January 18, 2021

      Frontpage

      NNPC moves to rehabilitate downstream infrastructure, openscontract bids

      January 15, 2021

  • TECHNOLOGY
  • MANUFACTURING
  • ANALYSIS
    • Analyst Insight

      CBN meeting and NSE in focus

      January 18, 2021

      Analyst Insight

      Once again, fiscal stimulus takes centre stage

      January 18, 2021

      Analyst Insight

      Organisations must learn from the WhatsApp story  

      January 18, 2021

      Analyst Insight

      Data privacy maturity model in organisations

      January 11, 2021

Frontpage

China approves arthritis drug for coronavirus treatment

March 5, 2020479 views0 comments

An anti-inflammation drug, Actemra (tocilizumab), manufactured by the Swiss pharmaceutical company, Roche, has been approved by the Chinese government for the treatment of patients who are developing severe complications from coronavirus.

Actemra is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs.

Roche was quoted as saying that a third party has initiated the trial independently to explore the efficacy and safety of the drug in coronavirus patients with cytokine release syndrome (CRS).

According to the online portal, Pharmaceutical Technology, the latest development comes as China’s National Health Commission announced that it was searching for new ways to combat the deadly virus, which has so far killed 3,300 persons, alongside 96,414 infections in 84 countries and territories.

In its latest treatment guidelines published online, the Chinese commission said the biologic drug Actemra can now be used to treat coronavirus patients who have severe lung damage and high IL-6 levels.

The Interleukin-6 (IL-6) is a protein produced by various cells. It helps regulate immune responses, which makes the IL-6 test potentially useful as a marker of immune system activation. IL-6 can be elevated with inflammation, infection, autoimmune disorders, cardiovascular diseases, and some cancers.

In 2010, Actemra secured approval from the US Food and Drug Administration for the treatment of rheumatoid arthritis.

The drug is capable of inhibiting high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases, FDA had noted.

Researchers in China have also put the 10-year-old medication to a clinical trial, and are expected to enrol a total of 188 patients with Covid-19 on it.

Share on Facebook Tweet Email
PreviousSenate okays Buhari’s $22.7bn loan request
NextRE: When Desperation Comes to Roost at NBET

Leave a comment

- Cancel reply

MARKET DATA

Market Videos

Recent Posts

  • Nigeria’s pension fund assets rise by N238bn in November, says PenCom
  • Nigeria equities opened weak on selloffs in large caps DangCem, FBN, Flour Mills
  • Nigeria aims for cost efficiency, safety, value in oil sector with centre of excellence
  • Naira down N3 at N475/$1 in street trading as T-Bills market put up bearish outing
  • Despite low risk appetite: NSE Lagos pulls stellar performance, outshines Jo’burg, Nairobi exchanges

World

Africa

Buhari, Okonjo-Iweala congratulate Adesina over reelection as AfDB President

Europe

EU businesses to cut investments in 2020, says EIB report

America

U.S. increases cost of visa application for Nigerians

Africa

Thatcher-Loving Nigeria Candidate Plans to Overhaul Economy

Africa

AfDB scales up industrialization pace on the continent, delivers improved business access to finance, skills, energy

Frontpage posts

Share of the world’s poor living in resource-rich countries may peak 75% in 2030

Frontpage March 9, 2018

1
2

Nigeria’s Sovereign Investment, others wooed to finance 10,000mw Africa SDG7 clean energy project

Frontpage October 3, 2019

3

Oil prices fall on oversupply concern as Libyan output fluctuates

Frontpage August 23, 2017

4

Private sector operators set agenda for Buhari’s second term

Frontpage May 29, 2019

5

PwC sees technology, data revolution driving Africa’s insurance industry

Frontpage September 5, 2018

SUPPORT

  • Photo Gallery
  • Help Centre
  • About Us
  • Accessibility

LEGAL & PRIVACY

  • Terms & Conditions
  • Privacy
  • Cookies
  • Copyright

SERVICES

  • Conferences & Events
  • Analysts Research
  • Advertising Rate
  • Ebooks

TOOLS

  • Portfolio
  • Newsletters
  • News feed
  • Currency Converter

SUBSCRIBE

Join us to get latest updates on business related news.

[mc4wp_form id="3076"]
  • ABOUT US
  • CONTACT US
  • CAREERS
  • TERMS & CONDITIONS
  • PRIVACY POLICY
Copyright 2017. All rights reserved. BusinessAMLive. A Businessnewscorp Member Company.